XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Ordinary shares
Preferred shares
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2022   62,878 488      
Beginning balance at Dec. 31, 2022 $ (21,145) $ 628 $ 5 $ 589,783 $ (585,220) $ (26,341)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (30,784)       (30,784)  
Other comprehensive (loss) income 315         315
Issuance of common stock, net of issuance costs (in shares)   1,564        
Issuance of common stock, net of issuance costs 11,913 $ 16   11,897    
Amortization of deferred issuance costs (16)     (16)    
Vesting of restricted shares (in shares)   22        
Employee share purchase plan share issuance (in shares)   14        
Employee share purchase plan share issuance 29     29    
Share-based compensation expense 1,522     1,522    
Ending balance (in shares) at Mar. 31, 2023   64,478 488      
Ending balance at Mar. 31, 2023 (38,166) $ 644 $ 5 603,215 (616,004) (26,026)
Beginning balance (in shares) at Dec. 31, 2022   62,878 488      
Beginning balance at Dec. 31, 2022 (21,145) $ 628 $ 5 589,783 (585,220) (26,341)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (95,216)          
Other comprehensive (loss) income 399          
Ending balance (in shares) at Jun. 30, 2023   89,321 5,194      
Ending balance at Jun. 30, 2023 143,192 $ 893 $ 52 848,626 (680,436) (25,943)
Beginning balance (in shares) at Mar. 31, 2023   64,478 488      
Beginning balance at Mar. 31, 2023 (38,166) $ 644 $ 5 603,215 (616,004) (26,026)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (64,432)       (64,432)  
Other comprehensive (loss) income 83         83
Issuance of common stock, net of issuance costs (in shares)   12,205 4,706      
Issuance of common stock, net of issuance costs 134,151 $ 122 $ 47 133,982    
Conversion of preferred stock into ordinary shares/ Mandatory exchange of notes, net of issuance costs (in shares)   12,347        
Conversion of preferred stock into ordinary shares/ Mandatory exchange of notes, net of issuance costs 102,162 $ 123   102,039    
Exercise of stock options (in shares)   291        
Exercise of stock options 1,750 $ 4   1,746    
Share-based compensation expense 7,644     7,644    
Ending balance (in shares) at Jun. 30, 2023   89,321 5,194      
Ending balance at Jun. 30, 2023 143,192 $ 893 $ 52 848,626 (680,436) (25,943)
Beginning balance (in shares) at Dec. 31, 2023   89,825 5,194      
Beginning balance at Dec. 31, 2023 87,739 $ 898 $ 52 855,452 (745,496) (23,167)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (27,342)       (27,342)  
Other comprehensive (loss) income (589)         (589)
Issuance of common stock, net of issuance costs (in shares)   640        
Issuance of common stock, net of issuance costs 9,250 $ 6   9,244    
Amortization of deferred issuance costs (3)     (3)    
Conversion of preferred stock into ordinary shares/ Mandatory exchange of notes, net of issuance costs (in shares)   5,194 (5,194)      
Conversion of preferred stock into ordinary shares/ Mandatory exchange of notes, net of issuance costs 0 $ 52 $ (52)      
Exercise of stock options (in shares)   390        
Exercise of stock options 3,356 $ 3   3,353    
Employee share purchase plan share issuance (in shares)   48        
Employee share purchase plan share issuance 584 $ 1   583    
Share-based compensation expense 5,389     5,389    
Ending balance (in shares) at Mar. 31, 2024   96,097 0      
Ending balance at Mar. 31, 2024 78,384 $ 960 $ 0 874,018 (772,838) (23,756)
Beginning balance (in shares) at Dec. 31, 2023   89,825 5,194      
Beginning balance at Dec. 31, 2023 87,739 $ 898 $ 52 855,452 (745,496) (23,167)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (41,164)          
Other comprehensive (loss) income (1,048)          
Ending balance (in shares) at Jun. 30, 2024   96,204 0      
Ending balance at Jun. 30, 2024 70,288 $ 961 $ 0 880,202 (786,660) (24,215)
Beginning balance (in shares) at Mar. 31, 2024   96,097 0      
Beginning balance at Mar. 31, 2024 78,384 $ 960 $ 0 874,018 (772,838) (23,756)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (13,822)          
Other comprehensive (loss) income (459)         (459)
Exercise of stock options (in shares)   107        
Exercise of stock options 723 $ 1   722    
Share-based compensation expense 5,462     5,462    
Ending balance (in shares) at Jun. 30, 2024   96,204 0      
Ending balance at Jun. 30, 2024 $ 70,288 $ 961 $ 0 $ 880,202 $ (786,660) $ (24,215)